The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

The Journal of Immunology, 2007, 179, 4580-4588
Copyright © 2007 by The American Association of Immunologists, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akilesh, S.
Right arrow Articles by Shaw, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akilesh, S.
Right arrow Articles by Shaw, A. S.

Neonatal FcR Expression in Bone Marrow-Derived Cells Functions to Protect Serum IgG from Catabolism1

Shreeram Akilesh*, Gregory J. Christianson{dagger}, Derry C. Roopenian{dagger} and Andrey S. Shaw2,*

* Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; and {dagger} The Jackson Laboratory, Bar Harbor, ME 04609

The neonatal FcR (FcRn) is a receptor that protects IgG from catabolism and is important in maintaining high serum Ab levels. A major site of expression of FcRn is vascular endothelial cells where FcRn functions to extend the serum persistence of IgG by recycling internalized IgG back to the surface. Because FcRn is expressed in other tissues, it is unclear whether endothelial cells are the only site of IgG protection. In this study, we used FcRn-deficient mice and specific antiserum to determine the tissue distribution of FcRn in the adult mouse. In addition to its expression in the vascular endothelium of several organs, we found FcRn to be highly expressed in bone marrow-derived cells and professional APCs in different tissues. Experiments using bone marrow chimeras showed that FcRn expression in these cells acted to significantly extend the half-life of serum IgG indicating that in addition to the vascular endothelium, bone marrow-derived phagocytic cells are a major site of IgG homeostasis.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Medical Scientist Training Program Training Grant T32 GM07200, NIDDK 52701, and 56597. The Core Facility (Washington University School of Medicine Hybridoma Center) was supported in part by the Department of Pathology and Immunology (Washington University School of Medicine) and by National Institutes of Health Grant P30 AR048335.

2 Address correspondence and reprint requests to Andrey S. Shaw, Department of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO 63110. E-mail address: shaw{at}pathbox.wustl.edu

3 Abbreviations used in this paper: FcRn, neonatal FcR; BMDM, bone marrow-derived macrophage; BMDC, bone marrow-derived dendritic cell; BAL, bronchoalveolar lavage.


Related articles in The JI:

IN THIS ISSUE

The JI 2007 179: 4297-4298. [Full Text]  



This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. Kim, S. Mohanty, L. P. Ganesan, K. Hua, D. Jarjoura, W. L. Hayton, J. M. Robinson, and C. L. Anderson
FcRn in the Yolk Sac Endoderm of Mouse Is Required for IgG Transport to Fetus
J. Immunol., March 1, 2009; 182(5): 2583 - 2589.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. P. Montoyo, C. Vaccaro, M. Hafner, R. J. Ober, W. Mueller, and E. S. Ward
Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice
PNAS, February 24, 2009; 106(8): 2788 - 2793.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Mi, S. Wanjie, S.-T. Lo, Z. Gan, B. Pickl-Herk, R. J. Ober, and E. S. Ward
Targeting the Neonatal Fc Receptor for Antigen Delivery Using Engineered Fc Fragments
J. Immunol., December 1, 2008; 181(11): 7550 - 7561.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S.-W. Qiao, K. Kobayashi, F.-E. Johansen, L. M. Sollid, J. T. Andersen, E. Milford, D. C. Roopenian, W. I. Lencer, and R. S. Blumberg
Dependence of antibody-mediated presentation of antigen on FcRn
PNAS, July 8, 2008; 105(27): 9337 - 9342.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. R. Mezo, K. A. McDonnell, C. A. T. Hehir, S. C. Low, V. J. Palombella, J. M. Stattel, G. D. Kamphaus, C. Fraley, Y. Zhang, J. A. Dumont, et al.
Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn
PNAS, February 19, 2008; 105(7): 2337 - 2342.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. T. Jindra, A. Hsueh, L. Hong, D. Gjertson, X.-D. Shen, F. Gao, J. Dang, P. S. Mischel, W. M. Baldwin III, M. C. Fishbein, et al.
Anti-MHC Class I Antibody Activation of Proliferation and Survival Signaling in Murine Cardiac Allografts
J. Immunol., February 15, 2008; 180(4): 2214 - 2224.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Akilesh, T. B. Huber, H. Wu, G. Wang, B. Hartleben, J. B. Kopp, J. H. Miner, D. C. Roopenian, E. R. Unanue, and A. S. Shaw
From the Cover: Podocytes use FcRn to clear IgG from the glomerular basement membrane
PNAS, January 22, 2008; 105(3): 967 - 972.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.